Healthcare provider profile · identity verified

Matthew Joseph Farley

Internal Medicine · SALT LAKE CITY, UT · NPI 1841618550

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	514	169
Levothyroxine Sodium	Levothyroxine Sodium	387	108
Amlodipine Besylate	Amlodipine Besylate	381	118
Omeprazole	Omeprazole	314	99
Rosuvastatin Calcium	Rosuvastatin Calcium	314	90
Losartan Potassium	Losartan Potassium	268	84
Lisinopril	Lisinopril	255	82
Trazodone Hcl	Trazodone Hcl	229	65
Gabapentin	Gabapentin	213	71
Potassium Chloride	Potassium Chloride	173	52
Tamsulosin Hcl	Tamsulosin Hcl	153	51
Simvastatin	Simvastatin	137	42
Metformin Hcl	Metformin Hcl	136	47
Metoprolol Succinate	Metoprolol Succinate	131	40
Duloxetine Hcl	Duloxetine Hcl	123	36
Pravastatin Sodium	Pravastatin Sodium	121	31
Alendronate Sodium	Alendronate Sodium	115	40
Furosemide	Furosemide	115	34
Sertraline Hcl	Sertraline Hcl	113	34
Metformin Hcl Er	Metformin Hcl	107	34
Eliquis	Apixaban	106	31
Tramadol Hcl	Tramadol Hcl	104	20
Finasteride	Finasteride	98	28
Mounjaro	Tirzepatide	98	18
Pantoprazole Sodium	Pantoprazole Sodium	91	28
Spironolactone	Spironolactone	90	21
Hydrochlorothiazide	Hydrochlorothiazide	87	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	11
Jardiance	Empagliflozin	87	23
Trulicity	Dulaglutide	82	11
Indapamide	Indapamide	80	22
Glimepiride	Glimepiride	72	25
Escitalopram Oxalate	Escitalopram Oxalate	71	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	16
Donepezil Hcl	Donepezil Hcl	66	14
Irbesartan	Irbesartan	65	19
Zolpidem Tartrate	Zolpidem Tartrate	64	25
Carvedilol	Carvedilol	61	20
Ezetimibe	Ezetimibe	60	18
Fluoxetine Hcl	Fluoxetine Hcl	59	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	18
Montelukast Sodium	Montelukast Sodium	56	18
Triamcinolone Acetonide	Triamcinolone Acetonide	56	18
Clopidogrel	Clopidogrel Bisulfate	55	16
Olmesartan Medoxomil	Olmesartan Medoxomil	55	13
Ozempic	Semaglutide	55	13
Fluticasone Propionate	Fluticasone Propionate	54	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	15
Chlorthalidone	Chlorthalidone	52	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	16
Allopurinol	Allopurinol	51	18
Albuterol Sulfate Hfa	Albuterol Sulfate	49	28
Celecoxib	Celecoxib	48	16
Alprazolam	Alprazolam	47	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	suppressed
Bupropion Xl	Bupropion Hcl	46	15
Topiramate	Topiramate	44	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	38	14
Estradiol	Estradiol	33	12
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Acyclovir	Acyclovir	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	15
Propranolol Hcl Er	Propranolol Hcl	28	11
Atenolol	Atenolol	27	suppressed
Icosapent Ethyl	Icosapent Ethyl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Prednisone	Prednisone	26	13
Januvia	Sitagliptin Phosphate	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	16
Synthroid	Levothyroxine Sodium	25	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Linzess	Linaclotide	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Cephalexin	Cephalexin	22	19
Lovastatin	Lovastatin	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Eplerenone	Eplerenone	20	suppressed
Colchicine	Colchicine	19	suppressed
Ramipril	Ramipril	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Victoza 3-Pak	Liraglutide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Buspirone Hcl	Buspirone Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Valsartan	Valsartan	17	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Xarelto	Rivaroxaban	15	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Famotidine	Famotidine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Nystatin	Nystatin	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Torsemide	Torsemide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error